Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 9 of 9 citing Abugreen: CNV subtype in first eyes predicts severity of ARM in fellow eyes. (0.12 sec) 

Age-related macular degeneration-emerging pathogenetic and therapeutic concepts


KM Gehrs, DH Anderson, LV Johnson, GS … - Annals of medicine, 2006 - informahealthcare.com
Today, the average life expectancy in developed nations is over 80 years and
climbing. And yet, the quality of life during those additional years is often
significantly diminished by the effects of age‐related, degenerative ...
Cited by 58 - Related articles - BL Direct - All 6 versions

Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal …


NE Gross, A Aizman, A Brucker, JM Klancnik, … - Retina, 2005 - pdfs.journals.lww.com
From The LuEsther T. Mertz Retinal Research Center, Manhat- tan Eye, Ear &
Throat Hospital, New York, New York. Reprint requests: Dr. Lawrence A. Yannuzzi,
The LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear & Throat ...
Cited by 36 - Related articles - BL Direct - All 5 versions

Second eye of patients with unilateral neovascular age-related macular degeneration: …


S Sivaprasad, WL Membrey, V Sivagnanavel, … - Eye, 2005 - nature.com
To investigate the correlation between morphological features of choroidal
neovascularisation (CNV) secondary to age-related macular degeneration (AMD) in
the first eye and the severity of age-related maculopathy (ARM) in the ...
Cited by 7 - Related articles - BL Direct - All 5 versions

Prognosis of untreated occult choroidal neovascularization


I Krebs, U Stolba, C Glittenberg, O Seyeddain … - Graefe's Archive for Clinical and Experimental …, 2007 - Springer
Abstract Purpose The aim of this investigation was to evaluate prognostic
factors influencing the short-term prognosis of occult choroidal
neovascularization (CNV). Methods A consecutive series of 107 untreated ...
Cited by 5 - Related articles - BL Direct - All 3 versions

Further assessment of the complement component 2 and factor B region associated with …


GJ McKay, G Silvestri, CC Patterson, RE … - Investigative Ophthalmology & Visual Science, 2009 - ARVO
RESULTS. Strong LD was measured across this region as far as the superkiller
viralicidic activity 2–like gene (SKIV2L). Nine SNPs were identified to be
significantly associated with the genetic effect observed at this locus. Of ...
Cited by 4 - Related articles - All 3 versions

Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy …


F Parmeggiani, D Gemmati, C Costagliola, A … - Pharmacogenomics, 2009 - Future Medicine
Age-related macular degeneration (AMD) complicated by subfoveal choroidal
neovascularization (CNV) is the leading cause of severe central blindness in
developed countries. AMD-related CNVs are distinguishable in classic and ...
Cited by 2 - Related articles - All 5 versions

Treatment of age-related macular degeneration: focus on ranibizumab


MS Spitzer, F Ziemssen, KU Bartz-Schmidt, F …, 2008 - pubmedcentral.nih.gov
Ranibizumab, a humanized antigen-binding fragment (Fab) that binds all isoforms
of VEGF-A, significantly slows down loss of vision and causes significant visual
improvement in many patients with choroidal neovascularization (CNV) due to ...
Cited by 2 - Related articles - All 6 versions

The time pattern of bilateral exudative age-related macular degeneration


GS Gudnadottir, KP Magnusson, E Stefansson, … - Acta Ophthalmologica Scandinavica, 2005 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 2 - Related articles - All 9 versions

CNV subtype in first eyes predicts severity of ARM in fellow eyes

- bmj.com [PDF] 
L Tong - British Medical Journal, 2004 - bjo.bmj.com
If you have a burning desire to respond to a paper published in BJO, why not
make use of our ''rapid response'' option? Log on to our web site
(www.bjophthalmol. com), find the paper that interests you, and send your ...
Related articles - All 7 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google